HIV PrEP for Trans Individuals
PrEP Considerations for Transgender and Nonbinary Individuals

Released: January 05, 2023

Expiration: January 04, 2024

Jill Blumenthal
Jill Blumenthal, MD, MAS

Activity

Progress
1
Course Completed

In this episode, Jill Blumenthal, MD, MAS, discusses HIV pre-exposure prophylaxis (PrEP) considerations for transgender and nonbinary individuals, including:

  • Providing gender-affirming care
  • Integrating PrEP and gender care
  • Taking a sexual history and addressing sexual health
  • PrEP efficacy and options for transgender individuals, including FTC/TDF, FTC/TAF, and long-acting CAB
  • The importance of reassuring transgender individuals that data suggest there are no drug–drug interactions between gender-affirming hormone therapy and any of the PrEP options